We have previously reported that the GLI transcription factors are activated in a SMO-independent manner via oncogenic pathways such as RAS/RAF signaling axis in human colon cancer cells that are hence more sensitive to inhibition of GLI instead of SMO [7], [8]. This evidence concerns the gene SMO and malignant colon neoplasm.